Viewing Study NCT01710995


Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2025-12-26 @ 9:42 PM
Study NCT ID: NCT01710995
Status: COMPLETED
Last Update Posted: 2012-10-19
First Post: 2012-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions
Sponsor: Norgine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module